indication

Abnormal Mental State

Competitive landscape projected to LB-102’s launch window

as of 2026-07-01
Competitive set
1
1 approved · 0 pipeline
Next guided milestone
2027-02-01
LB-102 — Adjunctive MDD (Ph2) trial initiation
LB-102 protection (issued)
2037
+4 pending families to 2047

Projection timeline

actual past → guided future · protection walls overlaid
26 events
2020
2024
2028
2032
2036
2040
2044
2048
today
LB-102 launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff

Competitive set

resolved drugs with trials in this indication
drugUnknown
US-approved 1997 · SEROQUEL XR
Phase 41 trial
Protection

Market size

prevalence as a range, not a number